• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$13.78 $0.00 (0.00%)

REAL-TIME: Last trade at

Momenta Pharmaceuticals

NASDAQ:MNTA

Jump to this page for:

Related Resources

Momenta Pharmaceuticals' Management Presents at Bank of America Merrill Lynch 2012 Health Care Conference (Transcript)

5/18/2012 by Seeking Alpha

Momenta to Present at the Bank of America Merrill Lynch 2012 Health Care Conference

5/11/2012 by GlobeNewswire

Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Focus Moves to Copaxone Trial

5/4/2012 by StreetInsider.com

Momenta Pharmaceuticals' CEO Discusses Q1 2012 Results - Earnings Call Transcript

5/3/2012 by Seeking Alpha

Momenta Pharma sees total operating expenses $22M-$28M/qtr for 2012

5/3/2012 by Theflyonthewall.com

Momenta Pharma cites deecrease in Enoxaparin product revenue

5/3/2012 by Theflyonthewall.com

Momenta Pharma reports Q1 EPS (10c), consensus 21c

5/3/2012 by Theflyonthewall.com

Biotech names with the highest probability of M&A activity at Goldman

4/23/2012 by Theflyonthewall.com

Momenta Pharmaceuticals Announces Date of First Quarter 2012 Financial Results Conference Call

4/20/2012 by NASDAQ

Momenta Pharmaceuticals Announces Date of First Quarter 2012 Financial Results Conference Call

4/20/2012 by GlobeNewswire

4 Biotech ETFs for a Healthy Portfolio

3/27/2012 by InvestorPlace

Momenta Pharma April calls active

3/21/2012 by Theflyonthewall.com

Momenta Pharmaceuticals' Management Presents at Barclays Capital 2012 Global Healthcare Conference (Transcript)

3/20/2012 by Seeking Alpha

EBD Group to host a conference

3/19/2012 by Theflyonthewall.com

Momenta Pharmaceuticals CEO Presents at 2012 Citi Global Health Care Conference (Transcript)

3/14/2012 by Seeking Alpha

Momenta to Present at the Barclays Capital Global Healthcare Conference

3/12/2012 by GlobeNewswire

Momenta Pharmaceuticals and Sunpeaks Ventures Making Headway in Lucrative Anticoagulant Market

3/12/2012 by Marketwire

Momenta Pharmaceuticals and Sunpeaks Ventures Making Headway in Lucrative Anticoagulant Market

3/12/2012 by StockWatch

Momenta to Present at the Cowen and Company 32nd Annual Health Care Conference

3/2/2012 by GlobeNewswire

Leerink's biotech analyst holds an analyst/industry conference call

2/29/2012 by Theflyonthewall.com

Momenta to Present at the 2012 Citi Global Health Care Conference

2/24/2012 by GlobeNewswire

A Forward Look, The Year Ahead - Featured Research on Momenta Pharmaceuticals, Inc. and Cubist Pharmaceuticals Inc

2/15/2012 by Broadcast Newsroom

A Forward Look, The Year Ahead - Featured Research on Momenta Pharmaceuticals, Inc. and Cubist Pharmaceuticals Inc

2/15/2012 by Marketwire

Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Mgmt Meeting Takeaways: FDA Desire to Use 505(j) for M356

2/14/2012 by StreetInsider.com

Momenta to Present at the Leerink Swann 2012 Global Healthcare Conference

2/13/2012 by GlobeNewswire

Momenta Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript

2/9/2012 by Seeking Alpha

Momenta Badly Missing Q4 Forecasts On Lower Sales

2/9/2012 by Investor's Business Daily

Momenta Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year End 2011

2/9/2012 by GlobeNewswire

Judge rules for FDA, against Sanofi, in generic Lovenox appeal, Bloomberg says

2/7/2012 by Theflyonthewall.com

Biotech Buyout Portfolio: Momenta Pharmaceuticals

2/6/2012 by Seeking Alpha

Momenta Pharma to be added to S&P 600; HealthSpring deleted as of 1/31 close

1/30/2012 by Theflyonthewall.com

Momenta Pharmaceuticals (MNTA) Replaces HealthSpring (HS) in S&P SmallCap 600

1/30/2012 by StreetInsider.com

S&P Indices Announces Change to U.S. Index

1/27/2012 by PR Newswire

Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Amphastar's Enox Back, Copaxone Ruling Next Catalyst

1/27/2012 by StreetInsider.com

Research Reports on Top Traded Stocks: Boston Scientific, Sirius, Momenta Pharmaceuticals, Gran Tierra Energy, Taseko Mines and TiVo

1/27/2012 by PR Newswire

Momenta Pharma price target lowered to $19 from $21 at Leerink

1/26/2012 by Theflyonthewall.com

24/7 Wall St. Closing Bell (GD, VALE, GMCR, GLW, CHK, ARG, ACAT, T, BMY, CAT, CY, LMT, MKC, MWW, POT, RTN, VIST, RNWK, MNTA, NFLX, EFSC)

1/26/2012 by 24/7 Wall Street

Momenta Pharmaceuticals Motion for Preliminary Injunction Against Amphastar Pharmaceuticals, Inc.,

1/26/2012 by NASDAQ

Momenta Pharmaceuticals Motion for Preliminary Injunction Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd. Stayed

1/26/2012 by GlobeNewswire

Momenta Pharma falls 20.1%

1/26/2012 by Theflyonthewall.com
See More Articles...